Register Now - Beyond Recruitment: The Future of Patient Site Engagement in Oncology Clinical Trials
News|Videos|October 17, 2026

2026 SCRS Global Site Solutions Summit: What's a Mistake Sponsors or CROs Make When Rolling Out New Trial Technology?

ProofPilot’s Lauren Briggs talks on why sponsors and CROs fail at tech rollouts by skipping change management, and pushes for the industry to judge trial technology by real workflow impact rather than feature checklists.

Lauren Briggs, chief customer officer, ProofPilot, identifies the most common mistake sponsors and CROs make as treating a technology rollout as a simple deployment rather than a true change management effort.

She argues that adopting any new tool inherently requires effort, since it disrupts established day-to-day habits, which is why ProofPilot stays hands-on from the start through the first 90 days and beyond, attending investigator meetings and site initiation visits where possible and focusing heavily on initial training so sites understand the actual value a platform brings to their workflow. Briggs also points to ProofPilot’s site advisory board as a differentiator, noting that sites directly influence product direction and new functionality, ensuring development genuinely serves site workflows rather than working against them, with that value then fed back to users on the platform.

Looking at the bigger picture, Briggs says she hopes sponsors, CROs, and sites leave this year’s SCRS Summit rethinking how they evaluate trial technology altogether, moving beyond individual feature checklists to consider the overall value and efficiency a platform brings to a site’s real day-to-day workflow.

She frames this as understanding what sites actually need in order to spend the most time possible with patients. Reflecting broader themes she heard throughout the conference, Briggs emphasizes the opportunity to consolidate the scattered, disparate tools sites currently juggle into a single, centralized place, ultimately keeping the focus on the patient and making sites’ daily operations meaningfully more efficient.


Related to this article

What Needs to Happen Beyond the Clinical Trial Modernization Act
In this video interview, Kent Thoelke, CEO of Paradigm Health, calls for safe harbor protections, CMS reimbursement safeguards, and funding mechanisms modeled on EHR meaningful use to help community and rural institutions participate in research on par with academic centers.
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
In this video interview, Rajneesh Patil, global head of AI, digital, and innovation in clinical development at Syneos Health, describes the industry’s trajectory toward a unified intelligence orchestration environment—and explains why the future isn’t one model that knows everything, but a trusted system that brings the right evidence to the right human decision.